ROG.SW

Equity

ROCHE GS

Health Care · Drug Manufacturers - General

$367.00

+367.00 (+0.00%)

Open

N/A

Day Range

$364.00 - $370.20

52W Range

$231.90 - $374.90

Volume

2M

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Latest News

UMB Financial, Texas Capital Bank, Simmons First National, Pinnacle Financial Partners, and Old National Bank Shares Are Falling, What You Need To Know

StockStory 11 minutes ago

The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders

Business Wire 12 minutes ago

OCT West Coast: China’s clinical trial infrastructure delivers upto 60% cost savings

Clinical Trials Arena 15 minutes ago

KeyCorp, First Merchants, Fifth Third Bancorp, FB Financial, and Cathay General Bancorp Stocks Trade Down, What You Need To Know

StockStory 16 minutes ago

Anthropic says it will challenge Pentagon in court over 'supply chain risk' label on its AI technology

Associated Press Finance 18 minutes ago

Fair Value Estimate

DDM Value

$114.57

220.3% overvalued

Growth: 1.4% | Req. return: 10%

Peers in Health Care

Symbol Name Price Mkt Cap Div Yield Change
CRSP CRISPR Therapeutics AG $60.14 N/A - +0.00%
AHCO AdaptHealth Corp. $9.15 N/A - +0.00%
ABBV AbbVie Inc. $232.08 N/A 2.87% +0.00%
ABCL AbCellera Biologics Inc. $3.61 N/A - +0.00%
ABT Abbott Laboratories $116.35 N/A 2.06% +0.00%
ATAI AtaiBeckley Inc. $3.63 N/A - +0.00%
NVO Novo Nordisk A/S $37.45 N/A 4.49% +0.00%
001540.KQ AHN-GOOK PHA $8,070.00 N/A 5.45% +0.00%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About ROCHE GS

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

www.roche.com →

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

60

Safe

Based on 4 fundamental factors

+ 9 years of growth

Analysis Tools

Sign in for analysis tools

Share